Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Structure, characterisation and application of an unspecific peroxygenase from Daldinia childiae

Alexander McKenziea, Claudia Clarka, Katy A. S. Cornishab, Jiacheng Lia, Jack Domenecha, Benjamin Mellinga, Miles P. H. Ralstona, Jared Cartwrightb, Nicholas P. Mulhollandc, William P. Unsworth*a and Gideon Grogan*a
aDepartment of Chemistry, University of York, Heslington, York, YO10 5DD, UK. E-mail: william.unsworth@york.ac.uk; gideon.grogan@york.ac.uk
bDepartment of Biology, University of York, Heslington, York, YO10 5DD, UK
cSyngenta, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK

Received 24th April 2026 , Accepted 11th June 2026

First published on 11th June 2026


Abstract

Unspecific peroxygenases (UPOs) have emerged as useful biocatalysts for the scalable and selective oxygenation of a large variety of organic molecules. UPOs have been divided into family I and family II enzymes, dependent upon sequence similarity and molecular weight, with family I being shorter in sequence. Here we report the characterisation and application of the family I UPO from Daldinia childiae (DchUPO). The enzyme was expressed in both Escherichia coli and Komagataella phaffii, yielding protein for kinetic and structural studies and biocatalytic application respectively. The structure of the enzyme revealed notable differences in the active site tunnel, compared with the well-studied family I artUPO, including F79 for V69 and F171 for I160. Notably, these differences were manifested in selectivity divergent from other UPOs when DchUPO was applied to preparative biotransformations; for example, (–)-menthol was converted exclusively into cis-6-hydroxymenthol in contrast to artUPO, which gave exclusively the tertiary alcohol 2,8-menthanediol.


Introduction

The selective oxygenation of hydrocarbons is an ongoing challenge in synthetic chemistry as abiotic oxidation methods are often unselective and require toxic reagents and/or harsh reaction conditions. Consequently, biocatalytic approaches to hydroxylation have been studied intensively and have for the most part focused on the activity of cytochromes P450 (P450s);1–3 heme-dependent oxygenases that use molecular oxygen, an external reductant (typically NAD(P)H) and auxiliary electron transfer proteins to form the active oxidant ‘Compound I’, an iron(IV) oxo species, in the active site.4 The requirements for reagents additional to the heme binding domain for P450 catalysis render their application for in vitro biocatalysis problematic. The discovery of unspecific peroxygenases (UPOs), which are single-domain heme-dependent oxygenases secreted by fungi, by Hofrichter and co-workers in 2004,5 identified a new group of useful oxygenative biocatalysts with a similar reactivity profile to that of P450s. A crucial difference between P450s and UPOs is that the addition of only hydrogen peroxide to a single protein domain is required to promote the formation of Compound I in UPOs to catalyse the oxygenation reaction.6 This greatly simplifies in vitro biocatalytic applications, especially as UPOs are stable, easy to express at a large volume, and amenable to storage as lyophilised powders for long periods. Since the initial discovery of the prototypical enzyme from Agrocybe aegerita (AaeUPO),5 many different enzymes from different fungal organisms have been described and applied to the transformation of organic substrates.7–9 These investigations have been greatly assisted by the development of robust methods for their heterologous expression in easy-to-grow hosts such as Komagataella phaffii (formerly Pichia pastoris)10–13 and in some cases Escherichia coli.14–16 The description of many UPOs has permitted their subdivision into two broad families based on their amino acid sequence length:17 family I enzymes, typified by the enzyme from Marasmius rotula (MroUPO),18 have a mean molecular weight of ≈26 kDa; family II enzymes such as AaeUPO5 are longer, with a mean molecular weight of ≈44 kDa, by virtue of an extended C-terminal domain. Interestingly, family I and II UPOs can exhibit divergent behaviour with respect to their oxygenation reactions.16,19–21 For example, in previous work we have shown that the family I enzyme artUPO (‘artificial peroxygenase’)16,22 transforms sulfides 1 into (S)-sulfoxide products (S)-2, while the PaDa-I variant of the family II enzyme AaeUPO10,11 (‘rAaeUPO-PaDa-I-H’ in this case; the ‘H’ indicates that the construct features a C-terminal histidine tag)23 produces (R)-sulfoxide products (R)-2 (Scheme 1A).16 These differences may be attributed to differences in their active sites: family II enzymes, such as rAaeUPO-PaDa-I,24 feature a number of phenylalanine residues in this region, perhaps conferring superior selectivity; however the active sites of family I enzymes such as MroUPO25 are not so sterically restricted and may overall be better at transforming larger substrates (Fig. 1).
image file: d6cb00141f-s1.tif
Scheme 1 (A) Previous work: Divergent UPO biotransformations promoted by family I and family II unspecific peroxygenases; (B) this work: structure, characterisation and application to the selective oxygenation of menthol.

image file: d6cb00141f-f1.tif
Fig. 1 (A) Two molecules of the DchUPO monomer in the asymmetric unit obtained using X-ray crystallography; (B) monomer B of DchUPO; (C) active site of DchUPO with amino acid side chains in the active site and approach tunnel labelled. F75 is shown in two conformations: those observed in monomer B and A are shown in green and coral respectively.

More recently, we uncovered similar enantio-divergent reactivity for the biotransformations of sulfenimines (e.g. 3), with (S)- and (R)-sulfinimines (S)-4 and (R)-4 generated in high ee from artUPO and rAaeUPO-PaDa-I-H respectively (Scheme 1A).21 The same pair of UPOs can also enable biotransformations with divergent chemoselectivity; for example, artUPO promotes the biotransformation of the agrochemical fenfuram 5 into pyrollinone 6 (in the presence of ammonium ions in the crude enzyme secretate), whereas under the same conditions rAaeUPO-PaDa-I-H catalyses aromatic hydroxylation to give 7 (Scheme 1A).20

In this manuscript, we describe work to extend our research into the activities and reactions of family I UPOs to the unspecific peroxygenase from Daldinia childiae (DchUPO). Expression of DchUPO was achieved first in E. coli, affording purified enzyme that permitted its analysis using kinetics and X-ray crystallography. Expression was then also performed using Komagataella phaffii, enabling the production of substantial amounts of DchUPO for application in the preparative scale oxygenation of terpenes. Most notably, DchUPO enabled the regio- and stereo-selective transformation of (–)-menthol (–)-8 into cis-6-hydroxymenthol 10 (Scheme 1B), in contrast to the outcome of biotransformations using artUPO and rAaeUPO-PaDa-I-H, both of which had previously been shown by us to give the tertiary alcohol p-methane 3,8-diol 9 as the sole product.19

Results and discussion

DchUPO was identified from among a number of family I UPOs during a search of the genomic databases using the sequence of MroUPO18 as a model. The enzyme has a sequence length of 262 amino acids (Fig. S1), although the predicted native signal sequence accounts for the first seventeen residues. The ‘mature’ protein is predicted to have a molecular weight of approximately 28.7 kDa, confirming it as a member of family I of shorter UPOs. The enzyme displays 29% full length sequence identity with MroUPO (Fig. S2) and also 33% with artUPO and 65% with both DcaUPO from Daldinia caldariorum15 and HspUPO from Hypoxylon sp. EC38,26 other family I UPOs that have been the object of attention in recent studies.

Expression in Escherichia coli

As the expression of family I UPOs had been achieved using E. coli as a heterologous host,14–16 we first ordered a suitably codon-optimised DchUPO gene (Fig. S3) in the standard pET-28a vector, with the native signal peptide removed and equipped with a N-terminal hexa-histidine tag. Expression in E. coli was successfully achieved (SI Section S2), and this permitted a three-step purification of DchUPObact using nickel affinity chromatography, anion exchange and size exclusion (SEC) (Fig. S4) to give homogeneous protein suitable for enzyme assays and crystallisation. The pure protein exhibited a Reinheitszahl value (Rz value, corresponding to the ratio of absorbance at 419 nm and 280 nm) of 3.24, as determined by a UV-Vis scan (Fig. S5). This pure protein was suitable for kinetic assays as had previously been performed for artUPO16 and also crystallisation trials.

Kinetic analysis

We first attempted to establish kinetic parameters for DchUPObact using the established peroxidase/peroxygenase substrates 2,2′-azino-bis(3-ethylbenzathiazoline-6-sulfonic acid (ABTS, Fig. S6A) and 5-nitro-1,3-benzodioxole (NBD, Fig. S6B and Table 1).27 DchUPO displayed a comparable Km to artUPO for NBD, but a 10-fold higher kcat. For ABTS kinetic determinations were complicated by pronounced substrate inhibition (Fig. S6A).
Table 1 Kinetic parameters for DchUPO compared against those obtained for artUPObact16 and HspUPO26 previously
  ABTS NBD
kcat (s−1) Km (μM) kcat (s−1) Km (μM)
a Not determined owing to pronounced substrate inhibition (Fig. S6A).
DchUPObact a a 48 121
artUPObact16 45 35 5 106
HspUPO26 17 30 10 18


Structure of DchUPO

The structure of DchUPO was determined by X-ray crystallography and refined to a resolution of 1.88 Å (SI Section S4). The crystals were in space group C21 and featured two molecules in the asymmetric unit (Fig. 2A). The monomers were complete from residues P21/W22 to P237 with no additional C-terminal density suggesting that residues Q238SPGTISKRTEKSSEKRAEKRCPFH262 were either too flexible to be modelled or had been cleaved in the crystallisation process. Although there were two molecules in the asymmetric unit, there was no evidence from size exclusion chromatography that DchUPO forms a dimer, and indeed the cysteine residue C232 in the family I artUPO that forms a disulfide bridge with C232 of its neighbour16 is absent in the sequence of DcaUPO15 as in HspUPO.26 The monomer structure (Fig. 2B) was analysed using the DALI server28 and found to have the highest homology to DcaUPO (PDB code 8IAG; 72% sequence identity using the truncated form of DchUPO; Z-score 38.8; rmsd 0.8 over 222 Cα atoms)29 and HspUPO (7O1X; also 72%; 38.7; 0.5 over 225 Cα atoms).26
image file: d6cb00141f-f2.tif
Fig. 2 Superimposition of DchUPO and artUPO active sites, each modelled with (–)-menthol 8 using Autodock VINA.35 Side chain and (–)-menthol carbon atoms for DchUPO and artUPO models are shown in green and blue respectively.

A comparison of the active site of DchUPO with artUPO, which has been the subject of many studies within our group16,19–21,30,31 revealed some similarities but also a number of interesting differences. The cysteine residue C34 and glutamate residue E175 are highly conserved as they are responsible for ligating to the heme iron and for assisting peroxide cleavage respectively. However, several substitutions in the channel approaching the heme in the active site were observed, which alter the topology of this important area for substrate recognition. These include L76 (DchUPO) for A66 (artUPO); F75 (L65), L72 (I62), A178 (F167) G174 (L163), F171 (I160) and V177 (A166) (Fig. 2C). F75 was observed to be in two different conformations in the monomer subunits: ‘closed’ in subunit ‘A’ and ‘open’ in subunit ‘B’, (Fig. 2C), indicative of flexibility and a possible gatekeeper role, governing substrate access to the active site. The differences between DchUPO and artUPO, especially the more sterically restrictive residues F79 and F171, appear to significantly change the topology of the active site tunnel and hence potentially the selectivity of DchUPO when challenged with substrates with a number of oxidatively susceptible C-H bonds.

Expression in Komagataella phaffii

We have previously shown that while the family I UPO artUPO can indeed be expressed in E. coli, the recombinant enzyme produced from bacteria is unstable under process conditions when the enzyme is exposed to hydrogen peroxide.16 Although the molecular basis for this is ambiguous, it appears that the glycosylation of the UPO confers stability to the enzyme under oxidative stress. We have hence routinely applied artUPO as a crude secretate from Komagataella phaffii as a biocatalyst in preparative scale biotransformations.16,19–21,30,31 This being the case, we expressed DchUPO also in K. phaffii, in an effort to obtain substantial amounts of stable biocatalyst for the purposes of preparative scale biotransformations (SI Section S5). The DchUPO gene was edited to remove the native signal peptide and subcloned into the pPICZαB vector under the control of the AOX promoter, as employed for the artUPO K. phaffii expression.16 Following transformation and small-scale experiments that employed Western blot analysis to confirm expression, a strain of P. pastoris X33 was grown in a fermenter on a 200 mL scale. After 4 d of methanol feeding, the cells were removed and the secretate was concentrated ten-fold using centrifugal concentrators to yield an enzyme preparation suitable for use in biotransformation reactions. The UV-Vis scan for the secretate containing crude DchUPOyeast is shown in Fig. S7 and the preparation presented a Reinheitszahl (Rz) value of 0.22.

DchUPO catalyses a regio-distinct hydroxylation of (–)-menthol

The different active site topology of DchUPO compared to artUPO suggested that this may give rise to alternate selectivities in biotransformations. We therefore challenged DchUPO with the transformation of ethylbenzene, in addition to selected terpene substrates (SI Section S6). Ethylbenzene is a common substrate used to test C–H oxygenation by UPOs, including in our previous work,16 where we describe its conversion into (R)-11a using rAaeUPO-PaDa-I-H and artUPO in combination with H2O2. To compare the reactivity of DchUPO to these previously reported biotransformations, ethylbenzene was reacted with DchUPO and 1.2 equivalents of H2O2 at pH 7. Conversion and ee were measured by GC (Scheme 2A and Fig. S8). Under these conditions, two major products were formed: alcohol (R)-11a with 45% conversion and 34% ee, and ketone 11b with 42% conversion. This outcome differs to that seen for UPOs previously tested by us, with the major difference being the formation of significant amounts of the higher oxidation state ketone product 11b. The enantioselectivity for the DchUPO reaction was the same as that observed using artUPO (both 34% ee in favour of the (R)-isomer; Fig. S9), which seems reasonable given that both are family I UPOs, although notably, each is far less enantioselective than the family II UPO rAaeUPO-PaDa-I-H (>95% ee).16,32
image file: d6cb00141f-s2.tif
Scheme 2 Biotransformations using DchUPO: (A) ethylbenzene; % values refer to conversions measured by GC; (B) (R)-carvone; (C) (+)-valencene; (D) (–)- and (+)-menthol. % values in these cases refer to isolated yields. For full preparative details, analytic details and product characterisation data, see SI Section S6.

Having established that DchUPO is able to promote C–H oxygenation, we moved on to test more complex terpene substrates. In these experiments, a ‘UPO-free’ secretate, derived from fermentation of K. phaffii cells that had not been transformed with a UPO gene, was applied in control reactions in parallel, in order to confirm that there was no hydroxylation reaction by K. phaffii secretate in the absence of enzyme. In our previous work, we demonstrated that artUPO is capable of transforming both enantiomers of carvone 12 to form epoxide 13 as a mixture of diastereoisomers on a preparative scale (up to 85% isolated yield).19 In this study, the preparative scale transformation of (R)-carvone (R)-12 was tested using DchUPO and 1.2 equivalents of H2O2, which delivered epoxide 13 in 21% isolated yield, as a ≈3[thin space (1/6-em)]:[thin space (1/6-em)]2 mixture of diastereoisomers (Scheme 2B). While the yield of this unoptimised preparative scale biotransformation was low, it is notable that DchUPO was able to promote the same transformation as the established enzyme artUPO. We were also interested to challenge DchUPO with a larger terpene substrate to test its steric limits, and chose (+)-valencene, given that we previously showed that artUPO is capable of converting it into a mixture of three oxidation products.19 However, using the same conditions used to transform (R)-carvone, no conversion was observed (Scheme 2C). This suggests that DchUPO may be more restrictive than artUPO with respect to its ability to accept larger substrates.19

As noted in the Introduction (Scheme 1B), biotransformations of the important flavour and fragrance molecule (±)-menthol 8 using artUPO and rAaeUPO-PaDa-I-H had previously been shown by us to give the tertiary alcohol p-methane 3,8-diol 9 as the sole product, with the same product being formed from both enantiomers of menthol.19 artUPO performs this preparative biotransformation especially well, affording diol 9 in 66% isolated yield in a gram-scale reaction. We therefore challenged DchUPO with both enantiomers of menthol, and interestingly, different products were obtained to those using the previously tested UPOs in both cases (Scheme 2D). For the DchUPO biotransformation of (–)-menthol (–)-8, regio- and stereoselective oxygenation was observed, enabling the isolation of a single product, cis-6-hydroxymenthol 10. A completely different regiochemical outcome was observed when the other menthol enantiomer (+)-8 was tested, with diols 14 and 15 isolated in 17% and 23% yields respectively, each as single diastereoisomers. For all three products 10, 14 and 15, the rigidity of the 6-membered ring framework permitted the straightforward assignment of the regio- and stereoselective oxygenation reactions, through consideration of the 3JH–H coupling constants in their 1H NMR data (SI Section S7 for full details).

In its biotransformation of 8, DchUPO was shown to give products of menthol oxygenation which, to our knowledge, had not been previously observed by microbial or enzymatic transformation. The case of the transformation of (−)-8 is especially interesting as only one major product, cis-diol 10 was obtained. Miyazawa and co-workers previously reported isolation and biological activity of the trans- form of this diol,33,34 but we have been unable to find a previous report of the cis isomer of (–)-10 in the literature. With (+)-8, other diol products 14 and 15 were obtained. Both of these compounds also appear to be unprecedented in the literature, thus these reactions give access to new products from the commercially important terpenes (–)-and (+)-menthol.

The regio-distinct hydroxylation of (–)-menthol (–)-8 by DchUPO was explored by modelling the substrate into the active site using Autodock VINA35 and comparing this with an equivalent model for artUPO, using a structure previously obtained by our group (Fig. 2, SI Section S8).16 The lowest energy pose for artUPO with (–)-8 clearly positions the isopropyl group towards the oxygen atom of the Fe[double bond, length as m-dash]O in the model. However, for DchUPO, this orientation seems to be disfavoured by the presence of F79 and F171, which, in place of V69 and I160 respectively, press the 6-position towards the oxygen of Fe[double bond, length as m-dash]O. The greater restrictions imposed by the phenylalanine residues in DchUPO are reminiscent of the active site environment in the family II AaeUPO, although those Phe residues are not conserved in the same places in AaeUPO-PaDa-I.24 However, the results together provide further evidence that the presence or absence of large aromatic residues in UPO active sites has a significant influence on reaction selectivity.

Conclusions

In this paper we have reported the expression and analysis of a family I UPO from Daldinia childiae (DchUPO). Family I UPOs are of significant interest as, not only do they perform oxygenation reactions with a range of complementary selectivities to family II UPOs, they also in some cases can be expressed E. coli, rather than Komagataella phaffii, making them more accessible targets and more amenable to directed evolution. It is useful therefore to identify and characterise new family I UPOs in order to broaden the knowledge of these enzymes but also to provide platforms for evolution of catalysts for transformations with different outcomes to those observed previously for other enzymes.

Author contributions

G. G., W. P. U., N. P. M. and J. C. designed and supervised experiments. A. M., C. C., K. A. S. C., J. L., J. D., B. M. and M. P. H. R. performed experiments. All authors contributed to the writing of the manuscript.

Conflicts of interest

There are no conflicts to declare.

Data availability

The data supporting this article have been included as part of the supplementary information (SI). Supplemenentary information is available. See DOI: https://doi.org/10.1039/d6cb00141f.

Crystallographic data for the DchUPO structure have been deposited in the Protein Data Bank (PDB)] under accession number 9TM7.

Acknowledgements

We are grateful to Syngenta and the EPSRC for funding a studentship for B.M. and also to the EPSRC for research grant EP/T01430X/1. We thank Sam Hart and Dr Johan P. Turkenburg for assistance with X-ray data collection and the Diamond Light Source for access to beamline I03 under proposal number mx32736.

Notes and references

  1. V. B. Urlacher and M. Girhard, Trends Biotechnol., 2019, 37, 882–897 CrossRef CAS PubMed.
  2. C. Liu and X. Chen, Catalysts, 2025, 15, 374 CrossRef CAS.
  3. Y. Qiao, X. Zhang, Q. Xu, I. Abe and A. Li, Green Synth. Catal., 2025 DOI:10.1016/j.gresc.2025.05.005.
  4. J. Rittle and M. T. Green, Science, 2010, 330, 933–937 CrossRef CAS PubMed.
  5. R. Ullrich, J. Nüske, K. Scheibner, J. Spantzel and M. Hofrichter, Appl. Environ. Microbiol., 2004, 70, 4575–4581 CrossRef CAS PubMed.
  6. X. Wang, R. Ullrich, M. Hofrichter and J. T. Groves, Proc. Natl. Acad. Sci. U. S. A., 2015, 112, 3686–3691 CrossRef CAS.
  7. Y. Wang, D. Lan, R. Durrani and F. Hollmann, Curr. Opin. Chem. Biol., 2017, 37, 1–9 CrossRef PubMed.
  8. M. Hobisch, D. Holtmann, P. Gomez de Santos, M. Alcalde, F. Hollmann and S. Kara, Biotechnol. Adv., 2021, 51, 107615 CrossRef CAS PubMed.
  9. D. T. Monterrey, A. Menés-Rubio, M. Keser, D. Gonzalez-Perez and M. Alcalde, Curr. Opin. Green Sustainable Chem., 2023, 41, 100786 CrossRef CAS.
  10. P. Molina-Espeja, E. Garcia-Ruiz, D. Gonzalez-Perez, R. Ullrich, M. Hofrichter and M. Alcalde, Appl. Environ. Microbiol., 2014, 80, 3496–3507 CrossRef PubMed.
  11. P. Molina-Espeja, S. Ma, D. M. Mate, R. Ludwig and M. Alcalde, Enzyme Microb. Technol., 2015, 73–74, 29–33 CrossRef CAS PubMed.
  12. P. Püllmann, A. Knorrscheidt, J. Münch, P. R. Palme, W. Hoehenwarter, S. Marillonnet, M. Alcalde, B. Westermann and M. J. Weissenborn, Commun. Biol., 2021, 4, 562 CrossRef PubMed.
  13. K. Ebner, L. J. Pfeifenberger, C. Rinnofner, V. Schusterbauer, A. Glieder and M. Winkler, Catalysts, 2023, 13, 206 CrossRef CAS.
  14. J. Carro, A. González-Benjumea, E. Fernández-Fueyo, C. Aranda, V. Guallar, A. Gutiérrez and A. T. Martínez, ACS Catal., 2019, 9, 6234–6242 CrossRef CAS.
  15. D. Linde, A. Olmedo, A. González-Benjumea, M. Estévez, C. Renau-Mínguez, J. Carro, E. Fernández-Fueyo, A. Gutiérrez and A. T. Martínez, Appl. Environ. Microbiol., 2020, 86, e02899-19 CrossRef.
  16. W. X. Q. Robinson, T. Mielke, B. Melling, A. Cuetos, A. Parkin, W. P. Unsworth, J. Cartwright and G. Grogan, ChemBioChem, 2023, 24, e202200558 CrossRef CAS PubMed.
  17. M. Hofrichter, H. Kellner, M. J. Pecyna and R. Ullrich, in Monooxygenase, Peroxidase and Peroxygenase Properties and Mechanisms of Cytochrome P450, ed. E. G. Hrycay and S. M. Bandiera, Springer International Publishing, Cham, 2015, pp. 341–368 DOI:10.1007/978-3-319-16009-2_13.
  18. G. Gröbe, R. Ullrich, M. J. Pecyna, D. Kapturska, S. Friedrich, M. Hofrichter and K. Scheibner, AMB Express, 2011, 1, 31 CrossRef.
  19. B. Melling, T. Mielke, A. C. Whitwood, T. J. C. O’Riordan, N. Mulholland, J. Cartwright, W. P. Unsworth and G. Grogan, Chem Catal., 2024, 4, 100889 CAS.
  20. B. Melling, K. A. S. Cornish, J. Cartwright, N. P. Mulholland, W. P. Unsworth and G. Grogan, ACS Catal., 2025, 15, 16115–16120 CrossRef CAS.
  21. J. Li, B. Melling, K. A. S. Cornish, N. Mulholland, J. Cartwright, W. P. Unsworth and G. Grogan, Nat. Commun., 2026, 17, 646 CrossRef CAS PubMed.
  22. J. Vind, L. Kiemer and E. Amourgi, 2016, WO2016207373A1.
  23. H. E. Bonfield, K. Mercer, A. Diaz-Rodriguez, G. C. Cook, B. S. J. McKay, P. Slade, G. M. Taylor, W. X. Ooi, J. D. Williams, J. P. M. Roberts, J. A. Murphy, L. Schmermund, W. Kroutil, T. Mielke, J. Cartwright, G. Grogan and L. J. Edwards, ChemPhotoChem, 2020, 4, 45–51 CrossRef CAS.
  24. M. Ramirez-Escudero, P. Molina-Espeja, P. Gomez de Santos, M. Hofrichter, J. Sanz-Aparicio and M. Alcalde, ACS Chem. Biol., 2018, 13, 3259 CrossRef CAS.
  25. D. Linde, E. Santillana, E. Fernández-Fueyo, A. González-Benjumea, J. Carro, A. Gutiérrez, A. T. Martínez and A. Romero, Antioxidants, 2022, 11, 891 CrossRef CAS PubMed.
  26. L. Rotilio, A. Swoboda, K. Ebner, C. Rinnofner, A. Glieder, W. Kroutil and A. Mattevi, ACS Catal., 2021, 11, 11511–11525 CrossRef CAS PubMed.
  27. M. Dolz, D. T. Monterrey, A. Beltrán-Nogal, A. Menés-Rubio, M. Keser, D. González-Pérez, P. G. de Santos, J. Viña-González and M. Alcalde, in Methods in Enzymology, ed. H. Renata, Academic Press, 2023, vol. 693, pp. 73–109 Search PubMed.
  28. L. Holm, A. Laiho, P. Törönen and M. Salgado, Protein Sci., 2023, 32, e4519 CrossRef CAS PubMed.
  29. T. Li, R. Jin, B. Wu, D. Lan, Y. Ma and Y. Wang, Chin. Chem. Lett., 2024, 35, 108701 CrossRef CAS.
  30. J. Li, K. A. S. Cornish, J. Cartwright, W. P. Unsworth and G. Grogan, Chem. Commun., 2025, 61, 13640–13643 RSC.
  31. J. Li, K. A. S. Cornish, B. Pogrányi, B. Melling, J. Cartwright, W. P. Unsworth and G. Grogan, Org. Biomol. Chem., 2025, 23, 4897–4901 Search PubMed.
  32. M. Kluge, R. Ullrich, K. Scheibner and M. Hofrichter, Green Chem., 2012, 14, 440–446 Search PubMed.
  33. M. Miyazawa, H. Kawazoe and M. Hyakumachi, J. Chem. Technol. Biotechnol., 2002, 77, 21–24 CrossRef CAS.
  34. M. Miyazawa, H. Kawazoe, Y. Sumi and M. Hyakumachi, J. Agric. Food Chem., 2003, 51, 1880–1883 CrossRef CAS PubMed.
  35. O. Trott and A. J. Olson, J. Comput. Chem., 2010, 31, 455–461 CrossRef CAS PubMed.

This journal is © The Royal Society of Chemistry 2026
Click here to see how this site uses Cookies. View our privacy policy here.